Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
Legend Biotech (LEGN) Stock Forecast & Price Target
277 Followers
See the Price Targets and Ratings of:
LEGN Analyst Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LEGN Stock 12 Month Forecast
Average Price Target
$81.33
▲(38.46% Upside)
| Highest Price Target$94.00 | Average Price Target$81.33 | Lowest Price Target$60.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Barclays
Reiterated
07/18/24
Scotiabank
Reiterated
07/18/24
H.C. Wainwright
Reiterated
07/18/24
BMO Capital
Reiterated
07/17/24
TD Cowen
Reiterated
07/15/24
Truist Financial
Assigned
07/15/24
Deutsche Numis
Reiterated
07/02/24
RBC Capital
Reiterated
06/21/24
Piper Sandler
Reiterated
06/17/24
BTIG
Reiterated
06/03/24
Jefferies
$94
Buy
$94.00
(60.03% Upside)
Assigned
05/23/24
Jefferies Issues a Buy Rating on Legend Biotech (LEGN)
Morgan Stanley
$85→$82
Buy
$82.00
(39.60% Upside)
Reiterated
05/17/24
Legend Biotech Corp. (LEGN) PT Lowered to $82 at Morgan StanleyMorgan Stanley analyst Matthew Harrison lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $82.00 (from $85.00) while maintaining a Overweight rating.
William Blair
―
Hold
―
Reiterated
05/13/24
William Blair Remains a Hold on Legend Biotech (LEGN)
J.P. Morgan
$80→$79
Buy
$79.00
(34.49% Upside)
Reiterated
05/07/24
Analysts Offer Insights on Healthcare Companies: Legend Biotech (NASDAQ: LEGN), IGM Biosciences (NASDAQ: IGMS) and Elanco Animal Health (NYSE: ELAN)
Cantor Fitzgerald
$82
Buy
$82.00
(39.60% Upside)
Initiated
04/03/24
Legend Biotech initiated with an Overweight at Cantor FitzgeraldLegend Biotech initiated with an Overweight at Cantor Fitzgerald
Best Analysts Covering Legend Biotech
Which Analyst Should I Follow If I Want to Buy LEGN and Sell After:
1 Month
xxx
Success Rate
7/11 ratings generated profit
Average Return
+2.55%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +2.55% per trade.
3 Months
xxx
Success Rate
6/10 ratings generated profit
Average Return
+14.45%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +14.45% per trade.
1 Year
Success Rate
8/10 ratings generated profit
Average Return
+28.84%
reiterated a buy rating 2 months ago
Copying Matthew Harrison's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +28.84% per trade.
2 Years
xxx
Success Rate
8/10 ratings generated profit
Average Return
+25.73%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +25.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LEGN Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
8
18
31
36
24
Buy
19
21
18
7
7
Hold
6
7
7
4
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
46
56
47
32
Each month's total comprises the sum of three months' worth of ratings.
LEGN Financial Forecast
LEGN Stock Forecast FAQ
What is LEGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Legend Biotech Corporation’s 12-month average price target is $81.33.
What is LEGN’s upside potential, based on the analysts’ average price target?
Legend Biotech Corporation has 38.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LEGN a Buy, Sell or Hold?
Legend Biotech Corporation has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
What is Legend Biotech Corporation’s price target?
The average price target for Legend Biotech Corporation is $81.33. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $94.00 ,the lowest forecast is $60.00. The average price target represents 38.46% Increase from the current price of $58.74.
The highest analyst price target is $94.00 ,the lowest forecast is $60.00. The average price target represents 38.46% Increase from the current price of $58.74.
What do analysts say about Legend Biotech Corporation?
Legend Biotech Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of LEGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.